Skip to main content
NCBI home page
Neuropsychopharmacology logoLink to Neuropsychopharmacology
. 2022 May 11;47(8):1583–1584. doi: 10.1038/s41386-022-01339-9

Correction to: Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial

Chadi G Abdallah 1,2,3,4,5,✉, John D Roache 6,7, Ralitza Gueorguieva 8, Lynnette A Averill 1,2,3,4, Stacey Young-McCaughan 6,7, Paulo R Shiroma 9, Prerana Purohit 1,2, Antoinette Brundige 6,7, William Murff 6, Kyung-Heup Ahn 2, Mohamed A Sherif 2,10, Eric J Baltutis 9, Mohini Ranganathan 2, Deepak D’Souza 2, Brenda Martini 1,2, Steven M Southwick 1,2, Ismene L Petrakis 1,2, Rebecca R Burson 11, Kevin B Guthmiller 12,13, Argelio L López-Roca 11, Karl A Lautenschlager 12, John P McCallin III 14, Matthew B Hoch 14, Alexandar Timchenko 14, Sergio E Souza 14, Charles E Bryant 14, Jim Mintz 6,7, Brett T Litz 15,16, Douglas E Williamson 17,18, Terence M Keane 16,19, Alan L Peterson 6,7,20, John H Krystal 1,2
PMCID: PMC9205895  PMID: 35545665

Correction to: Neuropsychopharmacology 10.1038/s41386-022-01266-9, published online 19 January 2022

In Table 1 of this article, the values in the row headed ‘CAPS-5’ have been corrected. They now read as shown below. The original article has been corrected.

Table 1.

Demographics and clinical characteristics.

Standard dose Low dose Placebo
n = 51 n = 53 n = 54
0.5 mg/kg 0.2 mg/kg placebo p value
Sex – male (%) 38 (74.5) 43 (81.1) 40 (74.1) 0.63
Mean age (SD) 43.2 (12.7) 45.2 (11.2) 42.0 (10.8) 0.37
White—Non-Hispanic 29 (56.9) 28 (52.8) 37 (68.5) 0.57
Black 7 (13.7) 7 (13.2) 6 (11.1)
Hispanic 12 (23.5) 11 (20.8) 8 (14.8)
Other 3 (5.9) 7 (13.2) 3 (5.6)
<12th grade, high school 6 (11.8) 5 (9.4) 7 (13.0) 0.66
Some college 20 (39.2) 17 (32.1) 15 (27.8)
College degree 21 (41.2) 25 (47.2) 22 (40.7)
Some graduate 4 (7.8) 6 (11.3) 10 (18.5)
Duty Status—Veteran 34 (66.7) 36 (67.9) 37 (68.5) 0.98
Active duty 17 (33.3) 17 (32.1) 17 (31.5)
Army 29 (56.9) 32 (60.4) 33 (61.1) 0.59
Navy 8 (15.7) 10 (18.9) 10 (18.5)
Air Force 4 (7.8) 6 (11.3) 7 (13.0)
Marine 10 (19.6) 5 (9.4) 4 (7.4)
# Deployments
  0 19 (37.3) 20 (37.7) 17 (31.5) 0.12
  1 15 (29.4) 7 (13.2) 11 (20.4)
  2 14 (27.5) 13 (24.5) 13 (24.1)
  3+ 3 (5.9) 13 (24.5) 13 (24.1)
Years military service 11.2 (7.5) 12.0 (8.6) 10.9 (8.3) 0.77
PCL-5 47.5 (14.5) 46.6 (17.7) 48.6 (12.8) 0.80
CAPS-5 38.5 (8.4) 40.4 (9.1) 38.8 (8.0) 0.38
MADRS 27.8 (9.3) 27.8 (10.3) 28.2 (8.4) 0.97
Open in a new tab

PCL-5 PTSD Checklist for DSM-5, CAPS-5 Clinician-Administered PTSD Scale for DSM-5, MADRS Montgomery-Åsberg Depression Rating Scale.

Articles from Neuropsychopharmacology are provided here courtesy of Nature Publishing Group

RESOURCES